An international research team led by the Department of Psychiatry, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has completed a long-term population-based research study to improve care for people with treatment-resistant schizophrenia (TRS), the most severe form of this mental health condition. The findings reinforce the importance of timely access to clozapine and provide the first large-scale evidence from a Chinese population to support a review of Hong Kong's long-term blood monitoring requirements.
❓ Unknown
First evidence from a Chinese population supports review of long-term blood monitoring for local clozapine use
Just now
November 18, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
This article is not about Iran. It reports on a medical research study by the University of Hong Kong regarding clozapine blood monitoring for schizophrenia treatment in Chinese populations. It has no relevance to Iranian affairs, politics, or policy.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
13 min ago •
More than meets the eye: Refugee reception in eastern Germany can vary by group composition
13 min ago •
Implanted electrodes restore function after severe muscle loss in early tests
13 min ago •